Merck & Co., Inc. (MRK) Drops While Finance Lifts the Dow to New Heights
The markets are back on the upswing today as the Dow Jones Industrial Average continues to push on to uncharted highs. As of 2:15 p.m.
Posts Tagged ‘NYSE:MRK’
Opko Health Inc.(OPK)’s Massive Insider Buys: Should Investors Follow Suit? – Alnylam Pharmaceuticals, Inc. (ALNY), Merck & Co., Inc. (MRK)
"There are many reasons for an insider to sell a stock, but only one to buy it: he expects to make money." So goes the saying.
Is There Any Hope for Eli Lilly & Co. (LLY)? – Merck & Co., Inc. (MRK), Pfizer Inc. (PFE)
Are we beating up too much on Eli Lilly & Co.
A Tough Road Ahead for This Big Pharma Partner: Codexis, Inc. (CDXS), Royal Dutch Shell plc (ADR) (RDS.A)
Bio-based enzyme producer Codexis, Inc. (NASDAQ:CDXS) reported financial results for the fourth quarter and full-year 2012 last week.
Exxon Mobil Corporation (XOM), Merck & Co., Inc. (MRK): Invest in these Companies During an Inflation Bull Market
Most fund managers, if you asked them in private, would likely concede that buying a 30 year bond with a yield that is less than inflation is not an ideal long term investing ...
The Perfect Cure for Hepatitis C? – Gilead Sciences, Inc. (GILD), Johnson & Johnson (JNJ)
Gilead Sciences, Inc. (NASDAQ:GILD)' sofosbuvir with Johnson & Johnson (NYSE:JNJ) and Medivir's simeprevir are a match made in heaven.
Only 3 Dow Stocks Missed Today’s Record-Breaking Rally: Merck & Co., Inc. (MRK), The Coca-Cola Company (KO)
Today's surge has brought the Dow Jones Industrial Average (Dow Jones Indices: .DJI) to a new nominal all-time high, surpassing the mark it reached on Oct. 9, 2007.
Pfizer Inc. (PFE), Amgen, Inc. (AMGN), Merck & Co., Inc. (MRK): Why Wouldn’t You Buy These Pharmaceutical Stocks?
Investors are always trying to find the right balance between risk andreward.
Last Week’s Big Dow Losers: Merck & Co., Inc. (MRK), United Technologies Corporation (UTX), Alcoa Inc (AA)
If you don't religiously follow the markets and are just seeing the weekly results for the first time, it would appear that this past week was simply a slight winner and nothing...
Healthcare Giant’s Giant Drug: Johnson & Johnson (JNJ)
Dow-30 component Johnson & Johnson (NYSE:JNJ) is a giant healthcare company, with exposure to the consumer products, medical devices, and pharmaceuticals arenas.
Merck & Co., Inc. (MRK): A Global Health Care Giant Doling Out a Massive Dividend
A SWOT analysis is a look at a company’s strengths, weaknesses, opportunities, and threats, and is a tremendous way to gain a detailed and thorough perspective on a company ...
3 Stocks Leading the Dow This Week: The Coca-Cola Company (KO), Hewlett-Packard Company (HPQ)
A quick glance at the markets a week ago and today might have you thinking it was a quiet week on Wall Street.
Zoetis Inc (ZTS): A Global Leader in Animal Health – Spinoff Opportunity?
Although spin-off situations offered investors compelling investment opportunities most of the time, investors should study each situation quite carefully to determine its own...
Merck & Co., Inc. (MRK)’s Low Cholesterol
Merck & Co., Inc. (NYSE:MRK) has to more heavily rely on top selling pharmaceuticals now that Singulair's off patent.
Invest in Treasuries? These Stocks Laugh at the Idea: Merck & Co., Inc. (MRK) and More
It's always the case. As an investment broker I had clients every week asking about treasuries.
This Sector Is Your Best Investment Over the Next Decade: Life Technologies Corp. (LIFE) and More
I admit it's sometimes difficult to look too far down the road when the market continues to head higher regardless of the economic news.
The Better Way To Play Drug Makers: Pfizer Inc. (PFE), Eli Lilly & Co. (LLY)
Analysts wonder if other drug companies will follow in the footsteps of Abbott Laboratories (NYSE:ABT) and spinoff different parts of their business.
Is AbbVie Inc (ABBV) Wasting Your Money?
Stock buybacks are generally considered a bullish signal on Wall Street.
5 Dividend Companies Favored by Top Investors: Entergy Corporation (ETR), BP plc (ADR) (BP)
I've been examining dividend stocks for nearly a year now, selecting what I feel are the absolute best for my own dividend portfolio.
Markets Were Ready to Break Records. Maybe Not Now.: Verizon Communications Inc. (VZ),
Yesterday, the Dow Jones Industrial Average closed just 128 points below its all-time high, while the S&P 500 ended the day just 35 points short of its own record.
Why the Dow Cratered 108 Points Today: Apple Inc. (AAPL), Tesla Motors Inc (TSLA), Merck & Co., Inc. (MRK)
Just when the markets seem to start humming along smoothly and lulling investors into a false sense of security, a day like today sneaks up and catches investors off-guard.
Has Johnson & Johnson (JNJ) Become the Perfect Stock?
One thing's for sure: You'll never discover truly great investments unless you actively look for them.
Caterpillar Inc. (CAT)’s Earnings Weigh Down the Dow
Seems like every day now the Dow Jones Industrial Average is touching a new yearly high. As of 2:25 p.m.
Better Dividend: Merck & Co., Inc. (MRK) or Pfizer Inc. (PFE)?
Neither company has a stellar track record when it comes to dividends.
Gilead Sciences, Inc. (GILD): A Pharmaceutical Growth Story You Can’t Afford To Miss
Gilead Sciences, Inc. (NASDAQ:GILD) is the world’s largest maker of HIV drugs, but has taken on a number of new initiatives to enter other areas of treatment.
Zoetis Inc (ZTS): 3 Foolish Reasons to Buy This Expensive Stock
Make no bones about it -- Zoetis Inc (NYSE:ZTS) is one expensive stock. It even might be the most expensive health-care stock for its size.
Is Eli Lilly & Co. (LLY) Being Wise About YZ?
It's now more than halfway through the period that Eli Lilly & Co. (NYSE:LLY) has called its "years YZ," a term describing the years spanning from 2011 to 2014.
3 Stocks Near 52-Week Lows Worth Buying: Stone Energy Corporation (SYG) and More
Just as we examine companies each week that may be rising past their fair value, we can also find companies potentially trading at bargain prices.
Pfizer Inc. (PFE) and More: Should Big Pharma Follow the Spinoff Trend?
Pfizer Inc. (NYSE:PFE) faced a rough 2012 after Lipitor's loss of exclusivity in November 2011.
Does the Arthritis Market Have Growing Pains? – AbbVie Inc (ABBV)
Research firm Decision Resources predicts that the rheumatoid arthritis market will modestly grow to $15 billion in the next decade.
Better Buy: Pfizer Inc. (PFE) or Zoetis Inc (ZTS)?
Pfizer Inc. (NYSE:PFE) recently spun off animal health firm Zoetis Inc (NYSE:ZTS) in the form of an IPO.
Merck & Co., Inc. (MRK)’s Dynamic Duo
Merck & Co., Inc. (NYSE:MRK) lost blockbuster asthma drug Singulair off the patent cliff last year, and the sales plunge quickly followed.
General Electric Company (GE) Defies a Dropping Dow
The Dow Jones Industrial Average is pulling back once again after yesterday's surge, falling just below the 14,000 mark it has flirted with over the past few weeks.
Hedge Fund Kahn Brothers’ Stock Picks for 2013: The New York Times Company (NYT) and More
Hedge funds and other major investors continue to file their 13Fs for the fourth quarter of 2012 this week, disclosing many of their long equity positions as of the end of December...
A Few Losers on a Mixed Market Day: McDonald’s Corporation (MCD), The Boeing Company (BA)
While a few industries and some stocks in particular have been negatively affected by President Obama's speech last night, for the most part investors treated today like just ...
How is the Smart Money Playing Mega-Dividend Stocks? – Merck & Co., Inc. (MRK), Intel Corporation (INTC), Verizon Communications Inc. (VZ)
Only 47 stocks in the S&P 500 currently pay a dividend yield in excess of four percentage points, and of this top decile, a little over half sport market capitalizations greater...
Is the Pharma Industry Facing Pharmageddon? Pfizer Inc. (PFE) and More
The pharmaceuticals industry has always been one of the riskiest in the market.
Threats to Company Earnings Cause the Dow Jones Industrial Average (.DJI) to Drop: Merck & Co., Inc. (MRK)
While it may still be too early to tell, predictions that the markets would collapse after last night's State of the Union address seem to be dead wrong.
Merck & Co., Inc. (MRK)’s Crash of a Titan
Merck & Co., Inc. (NYSE:MRK)'s blockbuster asthma and allergy treatment Singulair fell off patent last year -- wiping more than 60% of revenue off the company's top line.
Wall Street Loves Dynavax Technologies Corporation (DVAX). Should You?
Despite all of Wall Street's conflict and contention, a fortunate few companies enjoy unanimous support among professional analysts.
Pfizer Inc. (PFE) and Merck & Co., Inc. (MRK): 2 Dow Stocks We All Need but Shouldn’t Own
Here at The Motley Fool, we believe the best way to invest and maximize returns is by buying strong companies and owning them for a long time.
Why Depomed Inc (DEPO) Is Poised to Pull Back
Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, specialty pharmaceutical company Depomed...
Will Johnson & Johnson (JNJ) Win Approval for Its Diabetes Drug?
In addition to its well-known personal-care products such as Listerine and Neutrogena, Johnson & Johnson (NYSE:JNJ) boasts an impressive portfolio of market-leading therapeutic...
Has Gilead Sciences, Inc. (GILD) Become the Perfect Stock?
One thing's for sure: You'll never discover truly great investments unless you actively look for them.
Last Week’s Dow Losers: International Business Machines Corp. (IBM), Exxon Mobil Corporation (XOM)
Another wild week on Wall Street leaves investors basically were they were five days ago.
How Far Can This Blockbuster Take Johnson & Johnson (JNJ)?
Johnson & Johnson (NYSE:JNJ) may offer well-known personal care products such as Listerine and Neutrogena, but it also boasts an impressive portfolio of market-leading therapeutic...
Eli Lilly & Co. (LLY): If You’re Going to Fail, Fail Quickly
It's not particularly surprising given that the drug failed a phase 3 trial in December, but it's still disappointing for a company that could really use a positive result.
The Investor’s Guide to Zoetis Inc (ZTS): Pfizer Inc. (PFE), Merck & Co., Inc. (MRK)
Looking for the hottest name in health care? Right now it's not big pharma nor even a hot biotech firm making waves on Wall Street; it's newly minted animal health firm Zoetis...
Finding Alpha in the Healthcare Space: UnitedHealth Group Inc. (UNH), Merck & Co., Inc. (MRK), Pfizer Inc. (PFE)
I'm a big fan of healthcare stocks. Everyone spends money on healthcare at some point in his or her life. Sometimes circumstances are unfortunate, but there is good money ...
